{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:20:23Z","timestamp":1784013623227,"version":"3.55.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.biopha.2018.05.019","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T04:00:59Z","timestamp":1527220859000},"page":"652-660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Platelet rich plasma, stromal vascular fraction and autologous conditioned serum in treatment of knee osteoarthritis"],"prefix":"10.1016","volume":"104","author":[{"given":"Ali","family":"Fotouhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam","family":"Dolati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Aghebati-Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leili","family":"Aghebati-Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bmb\/lds038","article-title":"Epidemiology and burden of osteoarthritis","volume":"105","author":"Litwic","year":"2013","journal-title":"Br. Med. Bull."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2012.10.004","article-title":"Epidemiology of osteoarthritis","volume":"39","author":"Neogi","year":"2013","journal-title":"Rheum. Dis. Clin."},{"key":"10.1016\/j.biopha.2018.05.019_bib0015","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.blo.0000143938.30681.9d","article-title":"The impact of osteoarthritis: implications for research","volume":"427","author":"Buckwalter","year":"2004","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.019_bib0020","first-page":"571","article-title":"Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee","volume":"84","author":"Ochi","year":"2002","journal-title":"Bone Joint J."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.019_bib0025","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.arthro.2015.01.007","article-title":"Platelet-rich plasma inhibits mechanically induced injury in chondrocytes","volume":"31","author":"Xie","year":"2015","journal-title":"Arthrosc.: J. Arthrosc. Relat. Surg."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.019_bib0030","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s40141-016-0119-4","article-title":"Role of PRP in the treatment of knee osteoarthritis","volume":"4","author":"Georgy","year":"2016","journal-title":"Curr. Phys. Med. Rehabil. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.019_bib0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1302\/2058-5241.2.160004","article-title":"Platelet-rich plasma (PRP) for knee disorders","volume":"2","author":"Shahid","year":"2017","journal-title":"EFORT Open Rev."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12178-011-9088-5","article-title":"Risk factors for incident osteoarthritis of the hip and knee","volume":"4","author":"Chaganti","year":"2011","journal-title":"Curr. Rev. Musculoskelet. Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0045","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1186\/s12889-015-2529-0","article-title":"Osteoarthritis prevalence and modifiable factors: a population study","volume":"15","author":"Plotnikoff","year":"2015","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.biopha.2018.05.019_bib0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/ar3091","article-title":"New developments in osteoarthritis. Sex differences in magnetic resonance imaging-based biomarkers and in those of joint metabolism","volume":"12","author":"Maleki-Fischbach","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2018.05.019_bib0055","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.joca.2005.04.014","article-title":"A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis","volume":"13","author":"Srikanth","year":"2005","journal-title":"Osteoarthr. Cartil."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cger.2010.03.002","article-title":"Age-related changes in the musculoskeletal system and the development of osteoarthritis","volume":"26","author":"Loeser","year":"2010","journal-title":"Clin. Geriatr. Med."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00167-011-1818-0","article-title":"Biomechanical considerations in the pathogenesis of osteoarthritis of the knee","volume":"20","author":"Heijink","year":"2012","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"issue":"8","key":"10.1016\/j.biopha.2018.05.019_bib0070","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.joca.2009.03.002","article-title":"Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix","volume":"17","author":"Loeser","year":"2009","journal-title":"Osteoarthr. Cartil."},{"issue":"9","key":"10.1016\/j.biopha.2018.05.019_bib0075","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/art.10496","article-title":"Detection of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin\u20101\u03b2 and with chondrocyte resistance to insulin\u2010like growth factor 1","volume":"46","author":"Loeser","year":"2002","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.019_bib0080","doi-asserted-by":"crossref","first-page":"R380","DOI":"10.1186\/ar1499","article-title":"Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function","volume":"7","author":"Yudoh","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"46","key":"10.1016\/j.biopha.2018.05.019_bib0085","doi-asserted-by":"crossref","first-page":"31972","DOI":"10.1074\/jbc.M109.056838","article-title":"Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling pathways","volume":"284","author":"Yin","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0090","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00167-011-1705-8","article-title":"Biological aspects of early osteoarthritis","volume":"20","author":"Madry","year":"2012","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.019_bib0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrrheum.2011.199","article-title":"Etiology of osteoarthritis: genetics and synovial joint development","volume":"8","author":"Sandell","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2009.08.005","article-title":"The clinical relevance of genetic susceptibility to osteoarthritis","volume":"24","author":"Valdes","year":"2010","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.biopha.2018.05.019_bib0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-133-8-200010170-00016","article-title":"Osteoarthritis: new insights. Part 1: the disease and its risk factors","volume":"133","author":"Felson","year":"2000","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.rdc.2013.02.001","article-title":"Osteoarthritis: a review of strengths and weaknesses of different imaging options","volume":"39","author":"Guermazi","year":"2013","journal-title":"Rheum. Dis. Clin."},{"key":"10.1016\/j.biopha.2018.05.019_bib0120","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.joca.2006.11.009","article-title":"Atlas of individual radiographic features in osteoarthritis, revised","volume":"15","author":"Altman","year":"2007","journal-title":"Osteoarthr. Cartil."},{"issue":"8","key":"10.1016\/j.biopha.2018.05.019_bib0125","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/ard.2010.146407","article-title":"Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation","volume":"70","author":"Raynauld","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/BOR.0000000000000163","article-title":"Conventional and novel imaging modalities in osteoarthritis: current state of the evidence","volume":"27","author":"Demehri","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"issue":"11","key":"10.1016\/j.biopha.2018.05.019_bib0135","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00256-015-2217-2","article-title":"Predictive value of semi-quantitative MRI-based scoring systems for future knee replacement: data from the osteoarthritis initiative","volume":"44","author":"Hafezi-Nejad","year":"2015","journal-title":"Skeletal Radiol."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0140","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1148\/radiol.14140991","article-title":"Can structural joint damage measured with MR imaging be used to predict knee replacement in the following year?","volume":"274","author":"Roemer","year":"2014","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.biopha.2018.05.019_bib0145","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.rdc.2016.07.004","article-title":"Diagnosis and longitudinal assessment of osteoarthritis: review of available imaging techniques","volume":"42","author":"Demehri","year":"2016","journal-title":"Rheum. Dis. Clin."},{"key":"10.1016\/j.biopha.2018.05.019_bib0150","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2147\/JPR.S92090","article-title":"Management of knee osteoarthritis by combined stromal vascular fraction cell therapy, platelet-rich plasma, and musculoskeletal exercises: a case series","volume":"8","author":"Gibbs","year":"2015","journal-title":"J. Pain Res."},{"issue":"02","key":"10.1016\/j.biopha.2018.05.019_bib0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-0030-1247804","article-title":"Evaluation and treatment of osteochondritis dissecans lesions of the knee","volume":"21","author":"Detterline","year":"2008","journal-title":"J. Knee Surg."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12967-017-1242-4","article-title":"Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis","volume":"15","author":"Bansal","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2018.05.019_bib0165","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/454873","article-title":"Current surgical treatment of knee osteoarthritis","volume":"2011","author":"R\u00f6nn","year":"2011","journal-title":"Arthritis"},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0170","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/17453670610013538","article-title":"Unicondylar knee replacement for primary osteoarthritis: a prospective follow-up study of 1,819 patients from the finnish arthroplasty register","volume":"78","author":"Koskinen","year":"2007","journal-title":"Acta Orthop."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5435\/00124635-200801000-00003","article-title":"Unicompartmental knee arthroplasty","volume":"16","author":"Borus","year":"2008","journal-title":"JAAOS- J. Am. Acad. Orthop. Surg."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.019_bib0180","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1586\/17434440.3.5.585","article-title":"Surgical options for articular defects of the knee","volume":"3","author":"Kellett","year":"2006","journal-title":"Expert Rev. Med. Devices"},{"issue":"11","key":"10.1016\/j.biopha.2018.05.019_bib0185","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJMoa0708333","article-title":"A randomized trial of arthroscopic surgery for osteoarthritis of the knee","volume":"359","author":"Kirkley","year":"2008","journal-title":"New Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.019_bib0190","first-page":"1665","article-title":"Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee, knee surgery, sports traumatology","volume":"24","author":"Kanchanatawan","year":"2016","journal-title":"Arthroscopy"},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0195","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2214\/AJR.10.5975","article-title":"Musculoskeletal applications of platelet-rich plasma: fad or future?","volume":"196","author":"Lee","year":"2011","journal-title":"Am. J. Roentgenol."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.019_bib0200","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/0363546512471299","article-title":"Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial","volume":"41","author":"Patel","year":"2013","journal-title":"Am. J. Sports Med."},{"issue":"41","key":"10.1016\/j.biopha.2018.05.019_bib0205","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.18410\/jebmh\/2015\/964","article-title":"Use of autologous adipose tissue derived stromal vascular fraction in treatment of knee osteoarthritis and chondral lesions","volume":"2","author":"Tantuway","year":"2015","journal-title":"J. Evid. Based Med. Healthc."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.019_bib0210","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/acr.20036","volume":"62","author":"Schrama","year":"2010","journal-title":"Arthritis Care Res."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/THC-2008-16301","article-title":"Influence of bone density on total hip resurfacing arthroplasty in patients with osteonecrosis of the femoral head\u2013a radiological analysis","volume":"16","author":"Thorey","year":"2008","journal-title":"Technol. Health Care"},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.scispo.2011.12.007","article-title":"Applications cliniques du plasma riche en plaquettes (PRP) dans les l\u00e9sions tendineuses: revue de la litt\u00e9rature","volume":"27","author":"Smets","year":"2012","journal-title":"Sci. Sports"},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0225","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar4493","article-title":"Biology of platelet-rich plasma and its clinical application in cartilage repair","volume":"16","author":"Xie","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1517\/14712598.2012.632765","article-title":"Joint pathology and platelet-rich plasma therapies","volume":"12","author":"Andia","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2018.05.019_bib0235","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrrheum.2013.141","article-title":"Platelet-rich plasma for managing pain and inflammation in osteoarthritis","volume":"9","author":"Andia","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10","key":"10.1016\/j.biopha.2018.05.019_bib0240","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1177\/0363546511417792","article-title":"Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma","volume":"39","author":"Sundman","year":"2011","journal-title":"Am. J. Sports Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jbspin.2015.05.002","article-title":"Does platelet-rich plasma have a role in the treatment of osteoarthritis?","volume":"83","author":"Ornetti","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0250","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.otsm.2011.03.004","article-title":"The effects of platelet-rich plasma on cartilage: basic science and clinical application","volume":"19","author":"Fortier","year":"2011","journal-title":"Oper. Tech. Sports Med."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.019_bib0255","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00264-009-0793-2","article-title":"The regenerative effect of platelet-rich plasma on healing in large osteochondral defects","volume":"34","author":"Sun","year":"2010","journal-title":"Int. Orthop."},{"issue":"11","key":"10.1016\/j.biopha.2018.05.019_bib0260","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.joca.2013.07.017","article-title":"Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review","volume":"21","author":"Zhu","year":"2013","journal-title":"Osteoarthr. Cartil."},{"issue":"11","key":"10.1016\/j.biopha.2018.05.019_bib0265","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1177\/0363546511419278","article-title":"Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes","volume":"39","author":"van Buul","year":"2011","journal-title":"Am. J. Sports Med."},{"issue":"25","key":"10.1016\/j.biopha.2018.05.019_bib0270","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1016\/j.biomaterials.2011.05.002","article-title":"Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis","volume":"32","author":"Wu","year":"2011","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/scrt218","article-title":"Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors","volume":"4","author":"Amable","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2018.05.019_bib0280","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/bjsports-2012-091916","article-title":"Exercise and the platelet activator calcium chloride both influence the growth factor content of platelet-rich plasma (PRP): overlooked biochemical factors that could influence PRP treatment","volume":"49","author":"Hamilton","year":"2015","journal-title":"Br. J. Sports Med."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0285","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jcp.22274","article-title":"Molecular basis of anti\u2010inflammatory action of platelet\u2010rich plasma on human chondrocytes: mechanisms of NF\u2010\u03baB inhibition via HGF","volume":"225","author":"Bendinelli","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2018.05.019_bib0290","doi-asserted-by":"crossref","first-page":"e15384","DOI":"10.1371\/journal.pone.0015384","article-title":"Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases","volume":"5","author":"Coudriet","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2018.05.019_bib0295","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/832396","article-title":"Transplantation of nonexpanded adipose stromal vascular fraction and platelet-rich plasma for articular cartilage injury treatment in mice model","volume":"2013","author":"Van Pham","year":"2013","journal-title":"J. Med. Eng."},{"issue":"7","key":"10.1016\/j.biopha.2018.05.019_bib0300","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.joca.2010.03.013","article-title":"The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep model","volume":"18","author":"Milano","year":"2010","journal-title":"Osteoarthr. Cartil."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.019_bib0305","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/jor.22005","article-title":"Human platelet\u2010rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells","volume":"30","author":"Kr\u00fcger","year":"2012","journal-title":"J. Orthop. Res."},{"issue":"11","key":"10.1016\/j.biopha.2018.05.019_bib0310","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1002\/jbm.a.34254","article-title":"Platelet\u2010rich plasma loaded in situ\u2010formed hydrogel enhances hyaline cartilage regeneration by CB1 upregulation","volume":"100","author":"Lee","year":"2012","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"2","key":"10.1016\/j.biopha.2018.05.019_bib0315","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1941738111431801","article-title":"Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients","volume":"4","author":"Gobbi","year":"2012","journal-title":"Sports Health"},{"issue":"9","key":"10.1016\/j.biopha.2018.05.019_bib0320","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00402-013-1782-x","article-title":"Platelet-rich plasma in patients with tibiofemoral cartilage degeneration","volume":"133","author":"Hart","year":"2013","journal-title":"Arch. Orthop. Trauma Surg."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0325","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/JSM.0b013e31827c3846","article-title":"Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis","volume":"23","author":"Halpern","year":"2013","journal-title":"Clin. J. Sport Med."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0330","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.apmr.2013.11.006","article-title":"Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis","volume":"95","author":"Chang","year":"2014","journal-title":"Arch. Phys. Med. Rehabilit."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.019_bib0335","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00590-012-1037-5","article-title":"Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis","volume":"23","author":"Jang","year":"2013","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"issue":"12","key":"10.1016\/j.biopha.2018.05.019_bib0340","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/PHM.0b013e3181fc7edf","article-title":"Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study","volume":"89","author":"Sampson","year":"2010","journal-title":"Am. J. Phys. Med. Rehabilit."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.019_bib0345","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00167-010-1337-4","article-title":"Autologous matrix-induced chondrogenesis combined with platelet-rich plasma gel: technical description and a five pilot patients report","volume":"19","author":"Dhollander","year":"2011","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"issue":"10","key":"10.1016\/j.biopha.2018.05.019_bib0350","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s00167-011-1837-x","article-title":"Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single-versus double-spinning approach","volume":"20","author":"Filardo","year":"2012","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"issue":"12","key":"10.1016\/j.biopha.2018.05.019_bib0355","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1177\/0363546512461902","article-title":"Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis","volume":"40","author":"Cerza","year":"2012","journal-title":"Am. J. Sports Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0360","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ker303","article-title":"Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip","volume":"51","author":"S\u00e1nchez","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.biopha.2018.05.019_bib0365","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar2460","article-title":"Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect","volume":"10","author":"Koga","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0370","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/ar3735","article-title":"Direct transplantation of mesenchymal stem cells into the knee joints of Hartley strain guinea pigs with spontaneous osteoarthritis","volume":"14","author":"Sato","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"01","key":"10.1016\/j.biopha.2018.05.019_bib0375","doi-asserted-by":"crossref","first-page":"02","DOI":"10.15419\/bmrat.v1i01.11","article-title":"Symptomatic knee osteoarthritis treatment using autologous adipose derived stem cells and platelet-rich plasma: a clinical study","volume":"1","author":"Bui","year":"2014","journal-title":"Biomed. Res. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.019_bib0380","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s00167-013-2807-2","article-title":"Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis","volume":"23","author":"Koh","year":"2015","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"issue":"14","key":"10.1016\/j.biopha.2018.05.019_bib0385","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1089\/scd.2011.0722","article-title":"Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells","volume":"21","author":"Strioga","year":"2012","journal-title":"Stem Cells Dev."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.019_bib0390","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2106\/JBJS.M.00058","article-title":"Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study","volume":"96","author":"Vangsness Jr","year":"2014","journal-title":"JBJS"},{"issue":"4","key":"10.1016\/j.biopha.2018.05.019_bib0395","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/scrt126","article-title":"Adipose stem cells can secrete angiogenic factors that inhibit hyaline cartilage regeneration","volume":"3","author":"Lee","year":"2012","journal-title":"Stem Cell Res. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.019_bib0400","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/stem.1076","article-title":"Concise review: adipose\u2010derived stem cells as a novel tool for future regenerative medicine","volume":"30","author":"Mizuno","year":"2012","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.biopha.2018.05.019_bib0405","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage cells from human adipose tissue: implications for cell-based therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng."},{"issue":"12","key":"10.1016\/j.biopha.2018.05.019_bib0410","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.biopha.2018.05.019_bib0415","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00003086-200209000-00004","article-title":"Articular cartilage injuries","volume":"402","author":"Buckwalter","year":"2002","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0420","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1752-1947-5-296","article-title":"Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series","volume":"5","author":"Pak","year":"2011","journal-title":"J. Med. Case Rep."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0425","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2474-14-337","article-title":"Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints","volume":"14","author":"Pak","year":"2013","journal-title":"BMC Musculoskelet. Disord."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.019_bib0430","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.arthro.2012.11.017","article-title":"Mesenchymal stem cell injections improve symptoms of knee osteoarthritis","volume":"29","author":"Koh","year":"2013","journal-title":"Arthrosc.: J. Arthrosc. Relat. Surg."},{"issue":"11","key":"10.1016\/j.biopha.2018.05.019_bib0435","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.arthro.2014.05.036","article-title":"Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study","volume":"30","author":"Koh","year":"2014","journal-title":"Arthrosc.: J. Arthrosc. Relat. Surg."},{"issue":"7","key":"10.1016\/j.biopha.2018.05.019_bib0440","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1177\/0363546514529641","article-title":"Second-look arthroscopic evaluation of cartilage lesions after mesenchymal stem cell implantation in osteoarthritic knees","volume":"42","author":"Koh","year":"2014","journal-title":"Am. J. Sports Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0445","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0363546514554190","article-title":"Mesenchymal stem cell implantation in osteoarthritic knees: is fibrin glue effective as a scaffold?","volume":"43","author":"Kim","year":"2015","journal-title":"Am. J. Sports Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0450","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1089\/biores.2016.0024","article-title":"Regeneration of cartilage in human knee osteoarthritis with autologous adipose tissue-derived stem cells and autologous extracellular matrix","volume":"5","author":"Pak","year":"2016","journal-title":"BioResearch Open Access"},{"issue":"5","key":"10.1016\/j.biopha.2018.05.019_bib0455","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00063030-200721050-00004","article-title":"Autologous conditioned serum in the treatment of orthopedic diseases","volume":"21","author":"Wehling","year":"2007","journal-title":"BioDrugs"},{"issue":"11","key":"10.1016\/j.biopha.2018.05.019_bib0460","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0167-5699(91)90142-G","article-title":"Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro","volume":"12","author":"Dinarello","year":"1991","journal-title":"Immunol. Today"},{"issue":"22","key":"10.1016\/j.biopha.2018.05.019_bib0465","doi-asserted-by":"crossref","first-page":"14147","DOI":"10.1016\/S0021-9258(18)98655-2","article-title":"Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor","volume":"266","author":"Granowitz","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0470","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","article-title":"Interleukin-1 receptor antagonist: role in biology","volume":"16","author":"Arend","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2018.05.019_bib0475","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-2776(08)60535-0","article-title":"Interleukin-1 receptor antagonist","volume":"54","author":"Arend","year":"1993","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.biopha.2018.05.019_bib0480","first-page":"49","article-title":"The biological role of naturally-occurring cytokine inhibitors","volume":"30","author":"Arend","year":"1991","journal-title":"Br. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0485","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-065X.1994.tb00857.x","article-title":"IgG induction of IL\u20101 receptor antagonist production by human monocytes","volume":"139","author":"Arend","year":"1994","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.019_bib0490","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.4049\/jimmunol.147.5.1530","article-title":"IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently","volume":"147","author":"Arend","year":"1991","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2018.05.019_bib0495","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00011-003-1197-1","article-title":"The production of anti-inflammatory cytokines in whole blood by physico-chemical induction","volume":"52","author":"Meijer","year":"2003","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0500","doi-asserted-by":"crossref","DOI":"10.1093\/bmb\/lds016","article-title":"Autologous conditioned serum for the treatment of osteoarthritis and other possible applications in musculoskeletal disorders","volume":"105","author":"Frizziero","year":"2013","journal-title":"Br. Med. Bull."},{"issue":"10","key":"10.1016\/j.biopha.2018.05.019_bib0505","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.4049\/jimmunol.153.10.4766","article-title":"Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids","volume":"153","author":"Arend","year":"1994","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.019_bib0510","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar3050","article-title":"Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection","volume":"12","author":"Rutgers","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"08","key":"10.1016\/j.biopha.2018.05.019_bib0515","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-2004-821304","article-title":"Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains","volume":"25","author":"Wright-Carpenter","year":"2004","journal-title":"Int. J. Sports Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.019_bib0520","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.joca.2008.06.014","article-title":"Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis","volume":"17","author":"Baltzer","year":"2009","journal-title":"Osteoarthr. Cartil."},{"issue":"8","key":"10.1016\/j.biopha.2018.05.019_bib0525","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.019_bib0530","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2018.05.019_bib0535","first-page":"301720","article-title":"Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis","volume":"113","author":"Ismahil","year":"2013","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.019_bib0540","doi-asserted-by":"crossref","first-page":"585","DOI":"10.5999\/aps.2012.39.6.585","article-title":"The efficacy and safety of platelet-rich plasma and adipose-derived stem cells: an update","volume":"39","author":"Choi","year":"2012","journal-title":"Arch. Plast. Surg."},{"issue":"11","key":"10.1016\/j.biopha.2018.05.019_bib0545","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/mc.20675","article-title":"Multipotent adipose stromal cells and breast cancer development: think globally, act locally","volume":"49","author":"Zhao","year":"2010","journal-title":"Mol. Carcinog."},{"issue":"15","key":"10.1016\/j.biopha.2018.05.019_bib0550","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/pros.21206","article-title":"Adipose tissue\u2010derived stem cells promote prostate tumor growth","volume":"70","author":"Prantl","year":"2010","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.biopha.2018.05.019_bib0555","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.rbre.2015.07.002","article-title":"Platelet-rich plasma for osteoarthritis treatment","volume":"56","author":"Knop","year":"2016","journal-title":"Revista Brasileira de Reumatologia (English Edition)"},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0560","first-page":"e1768","article-title":"Adipose-derived stromal vascular fraction (SVF) for the treatment of osteoarthritis of the knee, functional outcome and anatomic recovery of the cartilage: a case report","volume":"4","author":"Correa","year":"2016","journal-title":"CellR4"},{"key":"10.1016\/j.biopha.2018.05.019_bib0565","first-page":"1","article-title":"Autologous adipose tissue-derived stromal vascular fraction cells application in patients with osteoarthritis","volume":"20","author":"Michalek","year":"2015","journal-title":"Cell Transpl."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.019_bib0570","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.scs.0000436746.21031.ba","article-title":"Adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical evaluation for cell-based therapies in patients with scars on the face","volume":"25","author":"Gentile","year":"2014","journal-title":"J. Craniofac. Surg."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218311697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218311697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:35:07Z","timestamp":1760096107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218311697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":114,"alternative-id":["S0753332218311697"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.019","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet rich plasma, stromal vascular fraction and autologous conditioned serum in treatment of knee osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}